Company Filing History:
6 out of 8 
1 out of 832,843 Years Active: 2022-2025
Title: Michael Palfreyman: Innovator in Chemical Compounds
Introduction
Michael Palfreyman is a notable inventor based in St. Petersburg, FL (US). He has made significant contributions to the field of chemical compounds, particularly in the development of therapeutic agents targeting serotonin receptors. With a total of seven patents to his name, Palfreyman's work is at the forefront of innovation in medicinal chemistry.
Latest Patents
Among his latest patents are "Deuterated Tryptamine Derivatives and Methods of Use" and "Therapeutic Phenethylamine Compositions and Methods of Use." The first patent focuses on chemical compounds that can be utilized in treating diseases associated with serotonin 5-HT receptors. The second patent discloses deuterated 2C—X phenethylamine compounds, which are aimed at treating various central nervous system (CNS) disorders and psychological disorders. These patents highlight his commitment to advancing therapeutic options in medicine.
Career Highlights
Throughout his career, Michael Palfreyman has worked with various companies, including Cybin Irl Limited. His innovative approach and dedication to research have positioned him as a key figure in the development of new therapeutic compounds. His work has the potential to impact the treatment of numerous psychological and CNS disorders.
Collaborations
Palfreyman has collaborated with notable individuals in his field, including Alex Nivorozhkin and Alex Belser. These collaborations have further enriched his research and development efforts, leading to groundbreaking advancements in medicinal chemistry.
Conclusion
Michael Palfreyman's contributions to the field of chemical compounds and his innovative patents demonstrate his significant role as an inventor. His work continues to pave the way for new therapeutic solutions in medicine.